RMD Resmed Inc
- Stocks
- Healthcare
- NYSE: RMD
Price (delayed)
$284.89
Market cap
$41.71B
P/E Ratio
29.83
Dividend/share
$2.19
EPS
$9.55
Enterprise value
$41.35B
ResMed is a San Diego, California-based medical equipment company. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea , chronic obstructive pulmonary disease , and other respiratory
Highlights
Resmed's quick ratio has soared by 79% YoY and by 8% from the previous quarter
The EPS has increased by 38% YoY and by 7% from the previous quarter
The price to earnings (P/E) is 28% lower than the 5-year quarterly average of 41.2 but 7% higher than the last 4 quarters average of 27.8
Key stats
What are the main financial stats of RMD
Market
Valuations
Earnings
Shares outstanding
146.41M
Market cap
$41.71B
Enterprise value
$41.35B
Price to earnings (P/E)
29.83
Price to book (P/B)
7
Price to sales (P/S)
8.12
EV/EBIT
24.65
EV/EBITDA
21.61
EV/Sales
8.04
Revenue
$5.15B
Gross profit
$3.05B
Operating income
$1.69B
Net income
$1.4B
EBIT
$1.68B
EBITDA
$1.91B
Free cash flow
$1.66B
Per share
Balance sheet
Liquidity
EPS
$9.55
EPS diluted
$9.51
Free cash flow per share
$11.33
Book value per share
$40.7
Revenue per share
$35.08
TBVPS
$31.78
Total assets
$8.17B
Total liabilities
$2.21B
Debt
$851.81M
Equity
$5.97B
Working capital
$2.49B
Debt to equity
0.14
Current ratio
3.44
Quick ratio
2.11
Net debt/EBITDA
-0.19
Margins
Efficiency
Dividend
EBITDA margin
37.2%
Gross margin
59.4%
Net margin
27.2%
Operating margin
32.7%
Return on assets
18.6%
Return on equity
25.5%
Return on invested capital
50.5%
Return on capital employed
23.4%
Return on sales
32.6%
Dividend yield
0.77%
DPS
$2.19
Payout ratio
22.9%
RMD stock price
How has the Resmed stock price performed over time
Intraday
0.06%
1 week
0.35%
1 month
13.05%
1 year
25.38%
YTD
24.57%
QTD
10.42%
Financial performance
How have Resmed's revenue and profit performed over time
Revenue
$5.15B
Gross profit
$3.05B
Operating income
$1.69B
Net income
$1.4B
Gross margin
59.4%
Net margin
27.2%
RMD's net income is up by 37% YoY and by 7% QoQ
RMD's operating income is up by 28% YoY and by 4.5% QoQ
Resmed's net margin has increased by 25% YoY and by 3.8% QoQ
RMD's operating margin is up by 16% year-on-year
Price vs fundamentals
How does RMD's price correlate with its fundamentals
Growth
What is Resmed's growth rate over time
Valuation
What is Resmed stock price valuation
P/E
29.83
P/B
7
P/S
8.12
EV/EBIT
24.65
EV/EBITDA
21.61
EV/Sales
8.04
The EPS has increased by 38% YoY and by 7% from the previous quarter
The price to earnings (P/E) is 28% lower than the 5-year quarterly average of 41.2 but 7% higher than the last 4 quarters average of 27.8
RMD's equity is up by 23% year-on-year and by 8% since the previous quarter
RMD's P/B is 18% below its 5-year quarterly average of 8.5 but 9% above its last 4 quarters average of 6.4
The P/S is 16% higher than the last 4 quarters average of 7.0
The company's revenue rose by 10% YoY and by 2.5% QoQ
Efficiency
How efficient is Resmed business performance
The company's return on invested capital rose by 47% YoY and by 9% QoQ
The ROA has increased by 25% YoY and by 2.2% from the previous quarter
The ROS has increased by 21% YoY and by 6% from the previous quarter
Resmed's ROE has increased by 14% YoY
Dividends
What is RMD's dividend history
DPS
$2.19
Dividend yield
0.77%
Payout ratio
22.9%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Resmed financials performed over time
Resmed's quick ratio has soared by 79% YoY and by 8% from the previous quarter
The current ratio has grown by 33% YoY
Resmed's debt is 86% lower than its equity
RMD's equity is up by 23% year-on-year and by 8% since the previous quarter
Resmed's debt to equity has decreased by 22% YoY and by 7% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.